ImageneBio (IMA) EBT (QoQ) (2020 - 2025)
ImageneBio (IMA) EBT (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | ImageneBio | 49.41 Mn | -85.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -803.09% |
| Jun 30, 2025 | 54.71% |
| Mar 31, 2025 | 64.93% |
| Dec 31, 2024 | -444.33% |
| Sep 30, 2024 | 76.71% |
| Jun 30, 2024 | 15.21% |
| Mar 31, 2024 | 17.97% |
| Dec 31, 2023 | -13.31% |
| Sep 30, 2023 | -1.33% |
| Jun 30, 2023 | -20.37% |
| Mar 31, 2023 | 10.35% |
| Dec 31, 2022 | 98.49% |
| Sep 30, 2022 | 51.02% |
| Jun 30, 2022 | -9,398.21% |
| Mar 31, 2022 | 25.94% |
| Dec 31, 2021 | 38.28% |
| Sep 30, 2021 | 8.81% |
| Jun 30, 2021 | 55.43% |
| Mar 31, 2021 | -285.52% |
| Dec 31, 2020 | -405.63% |